Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Liraglutide Alters Bone Marrow Exosome-Mediated miRNA Signal Pathways in Ovariectomized Rats with Type 2 Diabetes

BACKGROUND: Compared with normal postmenopausal women, estrogen deficiency and hyperglycemia in postmenopausal women with type 2 diabetes (T2DM) lead to more severe bone property degradation. Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been reported to improve bone condition...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jin, Fu, Ling-Zhi, Liu, Lu, Xie, Fen, Dai, Ru-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699170/
https://www.ncbi.nlm.nih.gov/pubmed/29133778
http://dx.doi.org/10.12659/MSM.906603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699170/
https://www.ncbi.nlm.nih.gov/pubmed/29133778
http://dx.doi.org/10.12659/MSM.906603

Ejemplares similares